879 related articles for article (PubMed ID: 20946413)
41. Recent Advances in the Diagnosis of Pneumocystis Pneumonia.
Song Y; Ren Y; Wang X; Li R
Med Mycol J; 2016; 57(4):E111-E116. PubMed ID: 27904052
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.
Rogina P; Skvarc M
Radiol Oncol; 2020 May; 54(2):221-226. PubMed ID: 32463392
[TBL] [Abstract][Full Text] [Related]
43. Development of a fully automated PCR assay for the detection of Pneumocystis jirovecii using the GENECUBE system.
Matsumura Y; Tsuchido Y; Yamamoto M; Nakano S; Nagao M
Med Mycol; 2019 Oct; 57(7):841-847. PubMed ID: 30590702
[TBL] [Abstract][Full Text] [Related]
44. Comparison of a commercial real-time PCR assay, RealCycler® PJIR kit, progenie molecular, to an in-house real-time PCR assay for the diagnosis of Pneumocystis jirovecii infections.
Guillaud-Saumur T; Nevez G; Bazire A; Virmaux M; Papon N; Le Gal S
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):335-337. PubMed ID: 28143789
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.
Robert-Gangneux F; Belaz S; Revest M; Tattevin P; Jouneau S; Decaux O; Chevrier S; Le Tulzo Y; Gangneux JP
J Clin Microbiol; 2014 Sep; 52(9):3370-6. PubMed ID: 25009050
[TBL] [Abstract][Full Text] [Related]
46. Detection of Pneumocystis jirovecii by nested PCR in HIV-negative patients with pulmonary disease.
Santos CR; de Assis ÂM; Luz EA; Lyra L; Toro IF; Seabra JCC; Daldin DH; Marcalto TU; Galasso MT; Macedo RF; Schreiber AZ; Aoki FH
Rev Iberoam Micol; 2017; 34(2):83-88. PubMed ID: 28214275
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of Pneumocystis jirovecii pneumonia (2010-2013): the first Croatian report.
Babic-Erceg A; Vilibic-Cavlek T; Erceg M; Mlinaric-Missoni E; Begovac J
Acta Microbiol Immunol Hung; 2014 Jun; 61(2):181-8. PubMed ID: 24939686
[TBL] [Abstract][Full Text] [Related]
48. Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests.
Orsi CF; Bettua C; Pini P; Venturelli C; La Regina A; Morace G; Luppi M; Forghieri F; Bigliardi S; Luppi F; Codeluppi M; Girardis M; Blasi E
New Microbiol; 2015 Jan; 38(1):75-84. PubMed ID: 25742150
[TBL] [Abstract][Full Text] [Related]
49. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
Su YS; Lu JJ; Perng CL; Chang FY
J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
[TBL] [Abstract][Full Text] [Related]
50. Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction.
Teh BW; Azzato FA; Lingaratnam SM; Thursky KA; Slavin MA; Worth LJ
Med Mycol; 2014 May; 52(4):427-32. PubMed ID: 24625674
[TBL] [Abstract][Full Text] [Related]
51. Molecular Diagnosis of
Goterris L; Mancebo Fernández MA; Aguilar-Company J; Falcó V; Ruiz-Camps I; Martín-Gómez MT
J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31578265
[No Abstract] [Full Text] [Related]
52. Real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia.
Fillaux J; Berry A
Methods Mol Biol; 2013; 943():159-70. PubMed ID: 23104289
[TBL] [Abstract][Full Text] [Related]
53. Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.
Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
Microbiol Spectr; 2021 Sep; 9(1):e0002621. PubMed ID: 34346746
[TBL] [Abstract][Full Text] [Related]
54. Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia.
Chumpitazi BF; Flori P; Kern JB; Brenier-Pinchart MP; Hincky-Vitrat V; Brion JP; Thiebaut-Bertrand A; Minet C; Maubon D; Pelloux H
Med Mycol; 2011 Oct; 49(7):704-13. PubMed ID: 21417683
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the FXG™: RESP (Asp+) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens.
Seah C; Richardson SE; Tsui G; Yu B; Thornback J; McTaggart L; Boggild A; Wengenack NL; Zhang SX
Med Mycol; 2012 Apr; 50(3):324-7. PubMed ID: 21859386
[TBL] [Abstract][Full Text] [Related]
56. Quantitative Pneumocystis jirovecii real-time PCR to differentiate disease from colonisation.
Tan SJ; Pryce TM; Haygarth EJ; Boan PA
Pathology; 2021 Dec; 53(7):896-901. PubMed ID: 34217515
[TBL] [Abstract][Full Text] [Related]
57. A study on the colonization of Pneumocystis jirovecii among outpatients during cancer chemotherapy and among healthy smokers.
Takemoto S; Ebara M; Hasebe S; Yakushijin Y
J Infect Chemother; 2017 Nov; 23(11):752-756. PubMed ID: 28843641
[TBL] [Abstract][Full Text] [Related]
58. Use of Induced sputum to determine the prevalence of Pneumocystis jirovecii in immunocompromised children with pneumonia.
Das CK; Mirdha BR; Singh S; Seth R; Bagga A; Lodha R; Kabra SK
J Trop Pediatr; 2014 Jun; 60(3):216-22. PubMed ID: 24425204
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of a commercial Loop-mediated Isothermal Amplification (LAMP) assay for rapid detection of Pneumocystis jirovecii.
Scharmann U; Kirchhoff L; Schmidt D; Buer J; Steinmann J; Rath PM
Mycoses; 2020 Oct; 63(10):1107-1114. PubMed ID: 32738076
[TBL] [Abstract][Full Text] [Related]
60. Performance of a molecular viability assay for the diagnosis of Pneumocystis pneumonia in HIV-infected patients.
de Oliveira A; Unnasch TR; Crothers K; Eiser S; Zucchi P; Moir J; Beard CB; Lawrence GG; Huang L
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):169-76. PubMed ID: 17049800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
